← Back to screener

Strata Critical Medical, Inc. SRTA

Rank #1766 · Nasdaq · $0.4B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
42.7
P/E
-14.1
P/B
1.64
ROE
-11.7%
Op. Margin
-15.3%
Debt Ratio
15%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E -14.1x, P/B 1.64x. Ranks in the top 55% of the universe.

Profitability ★☆☆☆☆
Weak

ROE -11.7%. Ranks in the top 79% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 15%. Ranks in the top 11% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆
Poor

Revenue decline of 34.8% year over year. Ranks in the top 96% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2019–––$0.0B––
2020–$-0.0B$0.0B$0.0B––
2021$0.0B$-0.0B$-0.0B$0.0B-37.021
2022$0.1B$-0.0B$-0.0B$0.0B-47.7402
2023$0.1B$-0.1B$-0.0B$0.3B-36.617
2024$0.2B$-0.1B$-0.1B$0.3B-30.322
2025$0.1B$-0.0B$-0.0B$0.2B-15.315

← See the full screener